Magnetar Financial LLC purchased a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,300,000 shares of the company’s stock, valued at approximately $23,972,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Tuttle Capital Management LLC acquired a new stake in Translational Development Acquisition in the fourth quarter valued at about $461,000. Wealthspring Capital LLC acquired a new stake in shares of Translational Development Acquisition during the 4th quarter valued at approximately $1,095,000. Schechter Investment Advisors LLC acquired a new stake in shares of Translational Development Acquisition during the 4th quarter valued at approximately $2,778,000. Periscope Capital Inc. acquired a new stake in shares of Translational Development Acquisition during the 4th quarter valued at approximately $3,688,000. Finally, Picton Mahoney Asset Management acquired a new stake in shares of Translational Development Acquisition during the 4th quarter valued at approximately $4,610,000.
Translational Development Acquisition Price Performance
TDACU stock opened at $10.17 on Thursday. The firm’s 50 day moving average is $10.09. Translational Development Acquisition Corp. has a 12-month low of $10.00 and a 12-month high of $10.30.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- Growth Stocks: What They Are, What They Are Not
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Makes a Stock a Good Dividend Stock?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Which Wall Street Analysts are the Most Accurate?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.